Study Period | 2021-2033 | CAGR | 6.52% |
Historical Period | 2021-2023 | Forecast Period | 2025-2033 |
Base Year | 2024 | Base Year Market Size | USD 7.08 billion |
Forecast Year | 2033 | Forecast Year Market Size | USD 13.32 billion |
Largest Market | North America | Fastest Growing Market | Asia Pacific |
The global magnetic resonance imaging (MRI) market size was valued at USD 7.08 billion in 2024 and projected to grow from USD 7.55 billion in 2025 to USD 13.32 billion by 2033, exhibiting a CAGR of 6.52% during the forecast period (2025-2033).
The global magnetic resonance imaging (MRI) market growth is driven by several factors, including the increasing prevalence of chronic diseases such as cancer, neurological disorders, and cardiovascular conditions, necessitating advanced diagnostic tools. Technological advancements, such as integrating artificial intelligence (AI) and machine learning in MRI systems, have enhanced imaging capabilities, reduced scan times, and improved diagnostic accuracy.
Moreover, the rising demand for non-invasive and radiation-free diagnostic procedures has further propelled the adoption of MRI systems. The expansion of healthcare infrastructure in emerging economies and increased healthcare spending also contribute to market growth. However, high costs associated with MRI systems and the need for specialised personnel may pose challenges. Nonetheless, ongoing research and development and strategic collaborations among key industry players are expected to create new opportunities, ensuring the MRI market's robust growth trajectory in the coming years.
The integration of artificial intelligence (AI) into MRI systems is revolutionising diagnostic imaging by enhancing speed, accuracy, and efficiency. AI-powered image reconstruction algorithms reduce noise and improve resolution, enabling quicker scans without compromising quality.
Beyond image processing, AI facilitates workflow optimisation through automated scheduling, patient positioning, and real-time image quality assurance, improving operational efficiency in busy clinical environments. These advances support personalised medicine by integrating imaging data with patient history and genomics for tailored treatment plans. As radiology departments face increasing demand and staff shortages, AI’s role becomes indispensable in meeting the challenges of modern healthcare.
The escalating incidence of chronic diseases such as cancer, stroke, neurological disorders, and cardiovascular ailments is a key driver boosting the demand for MRI systems worldwide. MRI’s ability to provide detailed, non-invasive soft-tissue imaging without ionising radiation makes it critical in early disease detection, treatment monitoring, and surgical planning. Neurological diseases, including Alzheimer’s and multiple sclerosis, require precise imaging to track disease progression, making MRI indispensable in neurology and neurosurgery. Additionally, the global rise in stroke cases underscores the importance of advanced MRI techniques such as diffusion-weighted imaging for rapid diagnosis, which can significantly improve patient outcomes.
Ageing populations worldwide, especially in developed countries, further fuel demand as chronic conditions become more prevalent. Lifestyle factors such as obesity, smoking, and sedentary behaviour exacerbate these trends, compelling healthcare systems to invest in advanced MRI technologies to manage growing patient loads efficiently.
Despite remarkable technological improvements, MRI systems' high acquisition and operational costs continue to restrain widespread adoption, particularly in resource-limited settings. The price of a state-of-the-art MRI machine can exceed several million dollars, making capital investment prohibitive for many hospitals and clinics, especially in low- and middle-income countries. Beyond procurement, maintenance costs, including periodic servicing, software updates, and specialised cooling system requirements, add to the financial burden.
Operational expenses also encompass the need for highly trained radiologists and MRI technologists, whose shortage in many regions limits the capacity to maximise existing infrastructure. In some cases, long procedure times and the need for patient sedation further reduce scanner availability and increase costs.
Additionally, reimbursement rates for MRI procedures vary widely across countries and insurance plans, often not covering the full cost, discouraging healthcare providers from expanding MRI services. This economic barrier creates disparities in diagnostic imaging access, particularly in rural or underserved populations.
Emerging markets represent a significant growth opportunity for the global MRI market due to rising healthcare investments, expanding medical infrastructure, and increasing awareness of advanced diagnostic technologies. Governments in countries like India, Brazil, and South Africa are prioritising healthcare modernisation, allocating funds to equip hospitals with advanced imaging systems. In India, the National Health Mission has allocated increased budgets for diagnostic infrastructure, facilitating MRI machine installation in tier-2 and tier-3 cities.
Innovative business models, including mobile MRI units and remote-controlled imaging, enable cost-effective deployment in underserved areas. Tele-radiology initiatives combined with remote MRI imaging technologies improve accessibility in rural and remote regions, mitigating previous geographic limitations.
North America leads the global MRI market, holding a significant share due to its advanced healthcare infrastructure, high adoption of cutting-edge technologies, and substantial healthcare expenditure. The region's focus on early disease detection and personalised medicine has spurred the demand for high-resolution imaging modalities like MRI. Collaborations between academic institutions, government agencies, and industry players have fostered innovation, leading to AI-integrated MRI systems that enhance diagnostic accuracy and workflow efficiency. Additionally, favourable reimbursement policies and a strong emphasis on preventive healthcare contribute to the region's market dominance. The U.S. remains the largest single market in North America, benefiting from ongoing FDA approvals of innovative MRI technologies and extensive clinical research networks that validate new imaging protocols.
The Asia-Pacific region is the fastest-growing MRI market, propelled by rising healthcare expenditures, expanding healthcare infrastructure, and increasing awareness of early disease detection. Countries like China, India, and Japan are witnessing rapid adoption of MRI technology, supported by government initiatives, increasing private healthcare investments, and public-private partnerships. Additionally, increasing urbanisation, rising income levels, and expanding insurance coverage further support the region’s market growth. The surge in chronic diseases, coupled with a rapidly ageing population, reinforces demand for advanced diagnostic services, with tele-radiology and remote imaging technologies improving accessibility in rural areas.
Europe holds a substantial share of the MRI market, driven by its well-established healthcare systems, emphasis on quality care, and adoption of advanced diagnostic technologies. Countries like Germany, France, and the UK are at the forefront, with significant investments in healthcare infrastructure, research, and innovation. The region’s focus on patient-centric care has led to the development and adoption of open MRI systems, which enhance patient comfort without compromising image quality. Moreover, government initiatives promoting early diagnosis and preventive care have increased MRI utilisation across various medical specialities. Cross-border healthcare collaborations and European Union funding for medical technology research further accelerate the adoption of innovative MRI solutions. Sustainability and energy efficiency in MRI operations are also growing priorities within European healthcare facilities.
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Closed MRI systems dominate the market due to their superior image quality and diagnostic capabilities. In 2024, they accounted for approximately 75.6% of the market share. These systems provide high-resolution images for accurate diagnosis, especially in complex neurological and musculoskeletal disorders. Their enclosed design allows for stronger magnetic fields, resulting in better signal-to-noise ratios and faster scan times. Despite concerns about patient comfort, advancements such as wider bores, shorter scan sequences, and noise reduction technologies have mitigated these issues, maintaining their preference in clinical settings. Additionally, hybrid MRI models that combine closed system performance with improved patient comfort are emerging, further solidifying the dominance of closed MRI. This segment also benefits from ongoing R&D focused on portable and ultra-high-field systems, which promise to enhance diagnostic capabilities further.
High field strength MRI systems, particularly those with 3 Tesla (3T) and above, are increasingly favoured for enhanced imaging capabilities. These systems offer improved spatial resolution and faster imaging, crucial for detailed neurological, vascular, and oncological assessments. The need for precise diagnostics in complex conditions and research applications drives the demand for high-field strength MRIs. Their ability to provide clearer images in shorter times enhances patient throughput and diagnostic confidence. Moreover, ultra-high field MRI systems (7 Tesla and beyond) are gaining traction in specialised research institutions and advanced clinical centres, enabling novel insights into brain function and pathology. Technological innovations such as cryogen-free magnets and AI-assisted imaging reconstruction also support the broader adoption of high-field MRI by reducing operational costs and increasing system reliability.
The brain and neurological application segment holds the largest market share, attributed to the rising prevalence of neurological disorders such as Alzheimer's, Parkinson's, and multiple sclerosis. MRI's non-invasive nature and superior soft tissue contrast make it the modality of choice for diagnosing and monitoring these conditions. Advancements like functional MRI (fMRI), diffusion tensor imaging (DTI), and arterial spin labelling (ASL) have expanded their utility in neuroscience research and clinical practice. The increasing ageing population further propels the demand for neurological MRI scans. Besides neurological uses, applications in musculoskeletal imaging, cardiovascular diagnostics, and oncology are also rapidly growing, driven by new contrast agents and imaging sequences that improve visualisation of tissues and lesions. Integration with AI-driven diagnostic tools also enhances the accuracy and speed of image interpretation across applications.
Hospitals are the primary end users of MRI systems, accounting for the largest market share. Their comprehensive infrastructure and diverse medical specialties necessitate advanced imaging modalities like MRI. Hospitals often serve as referral centers for complex cases, requiring high-end MRI systems for accurate diagnosis and treatment planning. Integrating MRI into emergency departments, surgical suites, and intensive care units underscores its critical role in hospital settings. Moreover, hospitals' ability to invest in cutting-edge technology ensures the adoption of the latest MRI advancements. Additionally, outpatient imaging centers and specialty clinics are increasingly acquiring MRI systems to meet the rising demand for convenient, cost-effective diagnostic services, although hospitals remain dominant due to their scale and multidisciplinary capabilities.
The global MRI market is highly competitive, with key players focusing on technological advancements, strategic partnerships, and geographic expansion to strengthen their market position.
Siemens Healthineers: Siemens Healthineers holds a significant share in the global market, attributed to its innovative product portfolio and strong global presence. The company focuses on integrating AI and advanced imaging technologies to enhance diagnostic accuracy and efficiency. Its commitment to R&D and strategic collaborations positions it as a leader in the MRI industry.
Latest News: